p. 78−86
2008-6687
Vol.10/No.2
p. 87−94
2008-6687
Vol.10/No.2
30%) with high (3+) intensity in the epidermis; there was no case negative forthymocyte selection-associated high mobility group box factor expression. Only oneeczematous dermatitis case had expression of thymocyte selection-associated highmobility group box factor-positive lymphocytes (>30%) with high intensity and 4 caseswere negative for thymocyte selection-associated high mobility group box factorexpression. The frequency of thymocyte selection-associated high mobility groupbox factor expressing lymphocytes was higher in biopsies from mycosis fungoidescompared to eczematous dermatitis (P<0.05). CD7- cases expressed more thymocyteselection-associated high mobility group box factor-positive lymphocytes in the dermisand epidermis, which were significantly correlated (P=0.013).Conclusion: Thymocyte selection-associated high mobility group box factor, as apositive marker, in combination with pan T cell markers (especially CD7-) can be usefulto detect mycosis fungoides malignant lymphoid cells.]]>
p. 95−102
2008-6687
Vol.10/No.2
60Gy). We collected patients’ saliva before the onsetof radiation and after 2 Gy of radiation to assess lactate dehydrogenase levels. The patientsreceived the stipulated oral and dental care. Data on incidence and severity of mucositiswas collected using a preform sheet and oral mucositis assessment scale published bythe Radiation Therapy Oncology Group throughout the 7-week treatment period.Results: Salivary lactate dehydrogenase increased with exposure to radiation(P<0.0001) and there was an observed association with mucositis severity (P<0.0001;r = 0.515).Conclusion: The present results have established, for the first time, that salivarylactate dehydrogenase could be a useful predictive marker to understand the developmentof radiation-induced mucositis in patients with head and neck cancer. The proximityof the oral cavity for regular observation and saliva collection is an added advantage.]]>
p. 103−110
2008-6687
Vol.10/No.2
p. 111−117
2008-6687
Vol.10/No.2
p. 118−124
2008-6687
Vol.10/No.2
p. 125−131
2008-6687
Vol.10/No.2
p. 132−138
2008-6687
Vol.10/No.2
p. 139−155
2008-6687
Vol.10/No.2
p. 156−159
2008-6687
Vol.10/No.2
p. 160−164
2008-6687
Vol.10/No.2
p. 165−165
2008-6687
Vol.10/No.2